GRIN Therapeutics
Team & Investors
Leadership, board of directors, and investment partners
Executives
0
Board Members
0
Investors
2
Total Funding
$275M
Investors
2 investors across all rounds
AP
Angelini Pharma
B
Blackstone
Explore More Data
Detailed analysis for GRIN Therapeutics
GRIN Therapeutics Leadership & Investors
GRIN Therapeutics is led by a team of experienced leaders. The company has attracted investment from 2 institutional and strategic investors.
Who Has Invested in GRIN Therapeutics?
GRIN Therapeutics has raised $275M from 2 investors including venture capital firms, private equity investors, and strategic partners.
Investment Opportunity
Accredited investors can access GRIN Therapeutics shares through secondary market platforms like Premier Alternatives, joining the company's existing institutional investor base.